Carbidopa Tablet
Product Images NDC 16714-067

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbidopa (NDC 16714-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Carbidopa Fig1)

This is a description of Carbidopa tablets, containing 25 mg of anhydrous Carbidopa USP. They are intended for use with Carbidopa-Levodopa or Levodopa in the treatment of Parkinson's disease. The package is a bulk container and not intended for dispensing. The recommended adult dosage and storage instructions are provided on the accompanying circular. The tablets should be kept out of reach of children. The product is manufactured by APL Healthcare Limited in Andhra Pradesh, India and distributed by Northstar R LLC in Memphis, TN. The NDC number is 16714-067-01. The document is revised on 04/2021 with M.L No.:04/NLR/AP/2016/F/CC.*

FDA Label Image

Chemical Structure (Carbidopa Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.